Skip to main content
. 2024 Jul 2;47(7):e24314. doi: 10.1002/clc.24314

Figure 4.

Figure 4

Comparison between GLP‐1 receptor agonists and placebo stratified by comorbidity in terms of (A) myocardial infarction, (B) stroke, and (C) hospitalization for heart failure. CI, confidence interval; GLP‐1, glucagon‐like peptide‐1; RR, relative risk.